| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer
1 company
Sundaram Preethi serves as a Chief Strategy Officer at CPRX. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $1.7M at current prices.
Historically, Sundaram Preethi's trades have earned a middling insider score of 53/100 across 4 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +0.7%.
The biggest single holding is CPRX (~$1.7M) as Chief Strategy Officer. The recent filings there lean toward selling, a net 78,924 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Strategy Officer | Sell | 3,924 | $26.41 | $103,648.84 | -4.5% | -21.3% | - | |
| Nov 11, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Strategy Officer | Sale+OE | 56,786 | $16.38 | $929,870.75 | -66.7% | +5.7% | -12.3% | |
| Sep 15, 2022 | CPRX Catalyst Pharmaceuticals, Inc. | Chief Strategy Officer | Sale+OE | 18,214 | $14.49 | $263,920.86 | -100% | +30.0% | -8.5% |